# A Data-Driven Framework for Identifying and Prioritizing RPA Opportunities in Healthcare Processes

arXiv: https://arxiv.org/abs/2609.09137 · HTML: https://mlsanity.com/paper/2609.09137/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 1 of its 30 references that are in the map.
- First posted on arXiv 8 Sep 2026.

## Builds on (most cited first, 1 of 1)

- [Robotic Process Automation Using Process Mining unicodex2013 A Systematic Literature Review](https://mlsanity.com/paper/2204.00751/) (2022)

## Abstract (arXiv)

Robotic Process Automation (RPA) is widely used to reduce administrative burden in United States hospitals, yet an estimated 30-50% of RPA initiatives underperform because processes are selected informally, without a repeatable method to catalogue candidates, prioritize them, match each to an automation tier -- a Python bot, an open-source orchestrator such as n8n, or an enterprise platform such as UiPath -- and forecast financial return before committing resources. We propose a four-module, data-driven framework unifying these decisions: a Process Taxonomy of twenty recurring hospital processes across five value streams; a Prioritization module deriving an Automation Suitability Index from an Analytic Hierarchy Process matrix with an explicit consistency check; a Tool-Tier Selection module recommending the least-cost technology sufficient for a process complexity, integration, and compliance profile; and a Return-on-Investment module quantifying labor savings, error-cost avoidance, payback, and net present value. Applied to a synthetic portfolio spanning all twenty processes, plus a reference data-flow architecture linking it to hospital EHR/payer/ERP systems: 12 of 20 clear the prioritization threshold; the ranking is robust to +/-20% weight perturbation (Spearman correlation 0.83, top-5 set preserved 97.7%, 2,000 Monte Carlo trials); an Automation Risk Index flags four qualifying processes as Critical risk; a budget-constrained portfolio optimization shows diminishing marginal NPV as spend scales from 400K to 1.03M; and a second Monte Carlo analysis shows portfolio NPV stays positive at its 5th percentile. The framework is a conceptual synthesis of the literature rather than an instrument calibrated on primary hospital data; we discuss HIPAA governance and a research agenda for empirical validation. A supplementary Python implementation accompanies the paper.